*No analysts have provided price targets for this stock.
Financial Performance
Financial Overview
No financial data available for this stock yet.
Company Profile
Company Details
Full Name
Turmeric Acquisition Corp.
Country
United States
CEO
Luke Evnin
Stock Information
Ticker Symbol
TMPM
Stock Exchange
NASDAQ
Industry
Blank Checks / SPAC
Unique Identifier
NASDAQ: TMPM
IPO Date
October 16, 2020
Description
Turmeric Acquisition is a newly organized blank check company incorporated in August 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on the ability of our management team to identify promising opportunities in the biotechnology sector, with an emphasis on oncology and rare disease therapeutics where our management has extensive experience in investing, operating and drug development. Our independent directors have extensive experience in clinical medicine, development and regulatory affairs, operations within academia as well as the healthcare and financial industry. All of our independent directors have led or been a part of leadership teams in biotechnology companies that have together generated billions in value for investors and helped develop numerous FDA approved drugs for patients. We believe that their breadth of experience will bolster our ability to thoroughly evaluate prospective candidates and successfully execute our initial business combination.